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The extent of lymphadenectomy for carcinoma of the thoracic esophagus 
remains debatable. A prospective study was initiated in August 1994 to 
evaluate the patterns of nodal spread after esophagectomy with three-field 
lymph node dissection. The hospital mortality rate was 3.3%. Nodal 
metastases occurred in 73% (22/30) of patients. The most commonly 
affected nodal groups were the lesser curvature nodes (57%), parahiatal 
nodes (42%), and the right recurrent nodes (35%). Cervical nodal metas- 
tasis occurred in 10 patients (35%) irrespective of tumor location or T 
status. The cervical field of dissection was as likely as the mediastinum to 
be a site of nodal disease. These findings should be considered when the 
operative strategy for esophageal carcinoma is planned. (J Thorac Cardio- 
vase Surg 1997;113:540-4) 
T he extent of surgical resection for carcinoma of the thoracic esophagus remains the subject of 
controversy. Advocates of limited resections are 
undoubtedly influenced by current trends in the 
treatment of breast cancer and maintain that pri- 
mary surgical therapy for esophageal cancer is, at 
best, of palliative benefit) Furthermore, most med- 
ical and radiation oncologists, dismayed by high 
local and distant failure rates after standard tech- 
niques of esophagectomy, have called into question 
the relevance of operation in the treatment of this 
disease.2, 3 Some surgeons have practiced a more 
radical resection technique in which an en bloc 
resection of the tumor-bearing esophagus i comple- 
mented by a radical lymphadenectomy of the lower 
and middle mediastinum, as well as of the upper 
abdomen. 4-6 Although the local failure rates were 
gratifyingly low, distant failure continued to occur in 
30% to 40% of patients] Additionally, we observed 
that the cervical ymph nodes were the first site of 
tumor recurrence in approximately 18% of patients 
in whom all lymph nodes were free of cancer 
metastases after en bloc resections] 
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During the past 10 to 15 years Japanese surgeons 
have consistently reported a distressingly high rate 
of tumor recurrence in the cervical nodes and have 
consequently added cervical node dissection (third 
field) to their standard two-field radical esophagec- 
tomy? The preliminary and intermediate-term e-
sults of three-field lymph node dissection reported 
thus far have been quite enlightening and appear to 
offer some patients a significant survival benefit. TM 
The increased morbidity of the procedure, particu- 
larly the increased likelihood of recurrent nerve 
injury, delayed its immediate adoption by many 
European and North American centers. However, 
recent preliminary reports from Europe have con- 
firmed the findings from the Far East.* 
In August 1994 we initiated a prospective study to 
evaluate esophagectomy with three-field lymph 
node dissection in patients with carcinoma of the 
thoracic esophagus. Our primary objectives were to 
determine the prevalence of cervical node metasta- 
sis in a North American-based patient group and to 
determine whether cervical node metastasis is an 
early or late event in the course of the disease. 
Methods 
A prospective study to evaluate three-field issection 
was initiated in August 1994. Patients were eligible only if 
the entire tumor was located within the tubular esophagus 
and there was no preoperative or intraoperative evidence 
of visceral metastasis. Tumors of the lower third of the 
esophagus were included only if they did not extend past 
*Personal communications from A. Lerut, MD, and A. Perrachia, 
MD, 1994. 
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Table I. Surgical procedure: right thoracotomy, 
laparotomy, cervicotomy 
Field Nodes 
Abdominal (parahiatal, lesser curve, left 
gastric, splenic, hepatic) 
Mediastinal (thoracic duct; lower, 
middle, and upper paraesophageal; 
subcarinal, aortopulmonary window, 
right and left level 9) 
Cervicothoracic (left and right re- 
current chains, lateral and poste- 
rior internal jugular, and supraclavicular) 
the gastroesophageal junction. Three-field issection was 
not done in patients in whom the tumor was located at or 
beyond the gastroesophageal junction and in those in 
whom resections were done for high-grade dysplasia. 
Between August 1994 and April 1996, 28 patients 
underwent subtotal esophagectomy with three-field is- 
section. The three fields of nodes dissected were standard- 
ized and lymph nodes were labeled by the operating 
surgeon in the operating room (Table I). Data from two 
additional patients who underwent the procedure before 
the initiation date of the study were retrospectively eval- 
uated and included in the analysis. 
Surgical procedure. Twenty-nine patients underwent 
resection through a right lateral thoracotomy followed 
by repositioning and simultaneous laparotomy and neck 
incision. One patient with a tumor of the upper third of 
the thoracic esophagus had the resection done by a 
neck incision, a partial sternotomy, and a laparotomy. 
In general all patients underwent an en bloc resection 
as previously described whereby the tumor-bearing 
esophagus was resected within an envelope of tissue 
containing the thoracic duct posteriorly, the pericar- 
dium anteriorly, and both pleural surfaces laterally. ~2 
After completion of the en bloc resection, the right and 
left recurrent nerves were exposed and lymph nodes 
along the course of both nerves were dissected. Lymph 
nodes, especially those along the right recurrent nerve, 
formed a continuous chain that extended through the 
thoracic inlet along the recurrent nerves into the cervi- 
cal paratracheal region. 
After closure of the thoracotomy, a laparotomy and a 
generous neck collar incision were done. The abdominal 
lymphadenectomy was done as previously described. ~2 In 
the neck the right and left recurrent nerves were exposed 
and the remainder of the adjacent chain of nodes re- 
moved. The clavicular head of the sternoduodenomastoid 
muscle was divided exposing the infraomohyoid compart- 
ment. The nodes posterior and lateral to the internal 
jugular vein and the supraclavicular nd infraomohyoid 
nodal basins were then excised. The dissection of the 
nodes in the superior mediastinum and the neck extended 
the operative time by approximately 1 hour. 
Patients were generally kept in the recovery room for 24 
hours, sedated and with mechanical ventilation of the 
lungs, and extubated the morning after the procedure. 






Upper third 2 
Middle third 8 








*All located in lower third. 
Table I I I .  Complications (n = 12) 
N % 
Pulmonary 11 36 
Bronchorrhea 5 
Pneumonia i * 
Intubation >72 hr 5 
Leaks 6 20 
Gastric tip neurosis 3 
Anastomotic leak 3 
Recurrent nerve injury 2 6 
Empyema 1 
Delirium tremens 1 
*Hospital death. 
Oral intake of liquids was begun on the fifth postoperative 
day and advanced to a general diet after the integrity of 
the anastomosis was confirmed by a barium swallow on 
the sixth or seventh postoperative day. Twenty-two pa- 
tients (73%) were discharged by postoperative day 12. 
Results 
There were 19 male and 11 female patients with a 
median age of 61 years (range 40 to 75). Tumor  
location, cell types, and final tumor  stages are shown 
in Table II. There was one hospital death (including 
death within 30 days of the procedure)  for an 
operat ive mortal i ty rate of 3.3%. Death  occurred as 
a result of bi lateral  antibiot ic-resistant Pseudomonas 
pneumonia  that developed within 72 hours after 
operat ion.  Twenty-two compl icat ions occurred in 12 
patients (1.8 per pat ient)  and are detai led in Table 
III. Pu lmonary compl icat ions were most common, 
including bronchorrhea that was significant in five 
patients and necessitated repeated bronchoscopy. 
A l though recurrent nerve injury occurred in two 
patients it was permanent  in only one and neither 
required tracheostomy. 
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Table IV. T status and cervical node metastasis 
T status All patients Patients with CNM 
1 5 2 
2 5 1 
3 20 7 
CNM, Cervical node metastasis. 
Patterns of spread. A total of 1801 lymph nodes 
were resected, or approximately 60nodes per case. 
Twenty-two patients (73%) had nodes positive for 
disease. The most commonly affected nodal groups 
were, in order of frequency, the lesser curvature 
nodes (57%), the parahiatal nodes (42%), and the 
right recurrent nerve nodes (35%). Five patients 
had only one positive node, 7 patients had 2 to 5, 
and 10 had more than 5 nodes positive for disease. 
A single field was affected by nodal metastasis in 10 
patients (6 abdominal only, 2 cervical only, 2 medi- 
astinal only). Two fields were involved in 8 patients 
and metastases were present in all three fields in 4 
patients. Overall the most commonly involved field 
was the abdominal (18 patients) followed by the 
cervical and mediastinal fields in 10 patients each. 
Prevalence of cervical node metastasis. Ten pa- 
tients (30%) had metastases to the cervical nodes 
(recurrent or deep cervical nodes, or both). Six 
patients had squamous cell carcinoma nd four had 
adenocarcinoma. Cervical node metastasis was seen 
in 6 (30%) of 20 patients with lower-third tumors 
(4/15 adenocarcinoma and 2/5 squamous cell tu- 
mors). Three of 8 patients and 1 of 2 patients with 
middle and upper-third squamous cell cancers, re- 
spectively, had cervical node metastasis. Ten pa- 
tients had negative nodes in the abdomen and 
mediastinum, and 2 of these had positive nodes in 
the neck. Among patients with squamous cell carci- 
noma, 2 had metastasis n the cervical nodes only, 
whereas in no patient with adenocarcinoma w s 
metastasis present in the cervical nodes alone. 
Are cervical node metastases early events? To 
determine the relative stage at which metastasis to
the cervical nodes occurs, we attempted tocorrelate 
the frequency of cervical node metastasis with the 
number of positive nodes and the depth of tumor 
penetration. The results are shown in Tables IV and 
V. Interestingly, metastases to the cervical nodes 
were equally prevalent among T1 and T3 tumors. 
Additionally, among five patients with only one 
node positive for disease, the cervical region was the 
site of metastasis in two patients and was thus 
equally likely to be the sole site of spread as the 
Table V. Number of nodes and cervical node 
metastasis 
No. of positive nodes All patients Patients with CNM 
1 5 2 
2-5 7 3 
>5 10 5 
CNM, Cervical node metastasis. 
perigastric or periesophageal region. These data 
suggest o us that spread to that nodal basin may 
occur at a relatively early stage of tumor develop- 
ment. 
Discussion 
To the best of our knowledge this is the first 
published report on the prevalence of metastasis to
the cervical nodes in adenocarcinoma of the esoph- 
agus. Notwithstanding the small number of patients 
in this study, it appears that cervical node metastasis 
occurs with similar frequency in adenocarcinoma as 
in squamous tumors. 
Our data, as well as those of others, 911' 13 would 
indicate that at least one third of patients who 
undergo an en bloc or standard esophagectomy 
would not be free of disease at the conclusion of the 
operative procedure. Although some might argue 
that recurrence is inevitable under such circum- 
stances, it is clear that the role of surgical resection 
is, at best, doubtful in the setting of an incomplete 
resection. 
The 30% prevalence of preoperatively unsus- 
pected cervical nodal metastases i  in accordance 
with the plethora of reports from Japanese and 
European surgeons. TM 13, In Europe both Lerut and 
Perrachia have reported similar results with an 
incidence of cervical nodal metastasis n patients 
who underwent operation in excess of 30% (person- 
al communications). In our patients the addition of 
the cervical field of dissection would have resulted in 
changing the TNM staging in at least four patients in 
whom metastases were present in the deep cervical 
nodes: two from stage III to IV (lymph), one from 
stage I to IV (lymph), and one from stage IIA to III 
(data not shown). If one were to consider disease in 
the recurrent nerve nodes as extrathoracic metasta- 
sis, then six additional patients would have been 
assigned a higher stage. 
In 1986, Tanabe and associates 14 reported on the 
patterns of lymph flow from the esophagus after 
*A. Lerut, MD, personal communication, 1994. 
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injection of technetium-labeled rhenium colloid into 
the esophageal wall. Uptake was routinely detected 
by scintillation counting in the upper mediastinal 
and cervical nodes and in the left gastric nodes after 
injection in the midthoracic esophagus. Our data 
seem to support the concept that spread to the 
upper mediastinal and cervical nodes may occur at a 
relatively early stage of esophageal carcinogenesis. 
In fact, the cervical field was involved with meta- 
static disease with a similar frequency to that in the 
mediastinal nodal basin. Metastatic spread to the 
cervical ymph nodes occurred at all levels of tumor 
penetration i to the esophageal wall. Furthermore, 
when metastasis was present in only one lymph 
node, the cervical region was as likely as the medi- 
astinal or the perigastric regions to be the site of 
spread. 
Debate continues regarding the efficacy of lymph 
node dissection in improving survival and will un- 
doubtedly extend to the concept of three-field lymph 
node dissection. Although this study cannot at this 
time predict a survival advantage for this technique, 
several authors have reported a possible salutary 
effect. Kato and coworkers 9 reported in 1991 a 30% 
5-year survival in patients in whom the cervical 
nodes were the only site of cancer spread. Matsu- 
bara and coworkers 13 have also previously reported 
similar observations in a large number of patients 
with squamous cell cancer of the thoracic esopha- 
gus. Among 29 patients in that study with only one 
positive node, 60% had the metastasis n the cervical 
region and 32% in the perigastric region. Survival in 
this "favorable" group was 75% and 68% at 3 and 5 
years, respectively. With the use of subtotal esoph- 
agectomy and three-field lymph node dissection 
Baba and coworkers 11 reported a 5-year survival of 
30% in patients with stage III disease. Akiyama and 
associates 1°reported their experience with this tech- 
nique with a similar 5-year survival for patients with 
stage III disease. These compelling data may force a 
complete reappraisal of the role of extended lymph- 
adenectomy in the treatment of esophageal carci- 
noma. 
The continued poor outcome of the majority of 
patients with carcinoma of the thoracic esophagus 
has prompted a barrage of trials of preoperative 
chemotherapy or chemoradiotherapy in an at- 
tempt to improve survival. 15-17 Unfortunately to 
date no randomized trial has documented a sur- 
vival benefit of preoperative therapy compared 
with operation alone. 18' 19 A widely quoted ran- 
domized trial by Herskovitz and coworkers 3 found 
that chemoradiotherapy is superior to radiother- 
apy alone with a 5-year survival of approximately 
30%. However, the local failure rate in that trial 
was at least 34%, which calls into question the 
adequacy of chemoradiation as a primary modal- 
ity of local control. Whereas the need for effective 
systemic agents that decrease distant failures is 
clear to most investigators, the role of an optimal 
modality of local control is not fully appreciated. 
Only a clear understanding of the patterns of local 
spread would allow one to develop an effective 
method of local control. 
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